HSBC upgraded Johnson & Johnson to Buy from Hold with a $170 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Johnson & Johnson price target lowered to $175 from $181 at RBC Capital
- Johnson & Johnson price target lowered to $170 from $180 at BofA
- J&J report ‘not alarming’ for Legend Biotech, says H.C. Wainwright
- Johnson & Johnson says no change to M&A strategy
- Johnson & Johnson says ‘off to solid financial start’ in 2024